Characterization of hydroxypropyl-beta-cyclodextrins used in the treatment of Niemann-Pick Disease type C1 | PLOS ONE
![IJMS | Free Full-Text | In Vitro and In Vivo Evaluation of 6-O-α-Maltosyl-β- Cyclodextrin as a Potential Therapeutic Agent Against Niemann-Pick Disease Type C IJMS | Free Full-Text | In Vitro and In Vivo Evaluation of 6-O-α-Maltosyl-β- Cyclodextrin as a Potential Therapeutic Agent Against Niemann-Pick Disease Type C](https://www.mdpi.com/ijms/ijms-20-01152/article_deploy/html/images/ijms-20-01152-g001.png)
IJMS | Free Full-Text | In Vitro and In Vivo Evaluation of 6-O-α-Maltosyl-β- Cyclodextrin as a Potential Therapeutic Agent Against Niemann-Pick Disease Type C
![Schematic mechanism of action of CDs in NPC (Niemann Pick Type C), PD... | Download Scientific Diagram Schematic mechanism of action of CDs in NPC (Niemann Pick Type C), PD... | Download Scientific Diagram](https://www.researchgate.net/publication/344454548/figure/fig2/AS:942243389128706@1601659738433/Schematic-mechanism-of-action-of-CDs-in-NPC-Niemann-Pick-Type-C-PD-Parkinsons.png)
Schematic mechanism of action of CDs in NPC (Niemann Pick Type C), PD... | Download Scientific Diagram
![Lysosomal-specific Cholesterol Reduction by Biocleavable Polyrotaxanes for Ameliorating Niemann-Pick Type C Disease | Scientific Reports Lysosomal-specific Cholesterol Reduction by Biocleavable Polyrotaxanes for Ameliorating Niemann-Pick Type C Disease | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsrep04356/MediaObjects/41598_2014_Article_BFsrep04356_Fig1_HTML.jpg)
Lysosomal-specific Cholesterol Reduction by Biocleavable Polyrotaxanes for Ameliorating Niemann-Pick Type C Disease | Scientific Reports
![Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1–2 trial - The Lancet Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1–2 trial - The Lancet](https://www.thelancet.com/cms/attachment/040179c4-fcc2-4dea-92cc-53e6777de36c/gr1.gif)
Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1–2 trial - The Lancet
![A human iPSC-derived inducible neuronal model of Niemann-Pick disease, type C1 | BMC Biology | Full Text A human iPSC-derived inducible neuronal model of Niemann-Pick disease, type C1 | BMC Biology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12915-021-01133-x/MediaObjects/12915_2021_1133_Figa_HTML.png)
A human iPSC-derived inducible neuronal model of Niemann-Pick disease, type C1 | BMC Biology | Full Text
Investigation of 2-Hydroxypropyl-β-Cyclodextrin Treatment in a Neuronal-Like Cell Model of Niemann–Pick Type C Using Quantitative Proteomics | Journal of the American Society for Mass Spectrometry
![2-Hydroxypropyl-gamma-cyclodextrin overcomes NPC1 deficiency by enhancing lysosome-ER association and autophagy | Scientific Reports 2-Hydroxypropyl-gamma-cyclodextrin overcomes NPC1 deficiency by enhancing lysosome-ER association and autophagy | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-020-65627-4/MediaObjects/41598_2020_65627_Fig8_HTML.png)
2-Hydroxypropyl-gamma-cyclodextrin overcomes NPC1 deficiency by enhancing lysosome-ER association and autophagy | Scientific Reports
![Monitoring the itinerary of lysosomal cholesterol in Niemann-Pick Type C1-deficient cells after cyclodextrin treatment[S] - Journal of Lipid Research Monitoring the itinerary of lysosomal cholesterol in Niemann-Pick Type C1-deficient cells after cyclodextrin treatment[S] - Journal of Lipid Research](https://www.jlr.org/cms/asset/d8b9eae7-ac30-4e96-b1f9-c0c658361a49/gr1.jpg)
Monitoring the itinerary of lysosomal cholesterol in Niemann-Pick Type C1-deficient cells after cyclodextrin treatment[S] - Journal of Lipid Research
![Investigation of 2-Hydroxypropyl-β-Cyclodextrin Treatment in a Neuronal-Like Cell Model of Niemann–Pick Type C Using Quantitative Proteomics | Journal of the American Society for Mass Spectrometry Investigation of 2-Hydroxypropyl-β-Cyclodextrin Treatment in a Neuronal-Like Cell Model of Niemann–Pick Type C Using Quantitative Proteomics | Journal of the American Society for Mass Spectrometry](https://pubs.acs.org/cms/10.1021/jasms.2c00342/asset/images/medium/js2c00342_0005.gif)
Investigation of 2-Hydroxypropyl-β-Cyclodextrin Treatment in a Neuronal-Like Cell Model of Niemann–Pick Type C Using Quantitative Proteomics | Journal of the American Society for Mass Spectrometry
![Linear Cyclodextrin Polymer Prodrugs as Novel Therapeutics for Niemann-Pick Type C1 Disorder | Scientific Reports Linear Cyclodextrin Polymer Prodrugs as Novel Therapeutics for Niemann-Pick Type C1 Disorder | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-27926-9/MediaObjects/41598_2018_27926_Fig1_HTML.jpg)
Linear Cyclodextrin Polymer Prodrugs as Novel Therapeutics for Niemann-Pick Type C1 Disorder | Scientific Reports
![Niemann–Pick type C disease: cellular pathology and pharmacotherapy - Wheeler - 2020 - Journal of Neurochemistry - Wiley Online Library Niemann–Pick type C disease: cellular pathology and pharmacotherapy - Wheeler - 2020 - Journal of Neurochemistry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/cb4188d2-a449-4117-93fc-397140fe7a12/jnc14895-fig-0003-m.jpg)
Niemann–Pick type C disease: cellular pathology and pharmacotherapy - Wheeler - 2020 - Journal of Neurochemistry - Wiley Online Library
![IJMS | Free Full-Text | Neurodegeneration in Niemann–Pick Type C Disease: An Updated Review on Pharmacological and Non-Pharmacological Approaches to Counteract Brain and Cognitive Impairment IJMS | Free Full-Text | Neurodegeneration in Niemann–Pick Type C Disease: An Updated Review on Pharmacological and Non-Pharmacological Approaches to Counteract Brain and Cognitive Impairment](https://www.mdpi.com/ijms/ijms-22-06600/article_deploy/html/images/ijms-22-06600-g001.png)
IJMS | Free Full-Text | Neurodegeneration in Niemann–Pick Type C Disease: An Updated Review on Pharmacological and Non-Pharmacological Approaches to Counteract Brain and Cognitive Impairment
![Investigating the Mechanism of Cyclodextrins in the Treatment of Niemann‐ Pick Disease Type C Using Crosslinked 2‐Hydroxypropyl‐β‐cyclodextrin,Small - X-MOL Investigating the Mechanism of Cyclodextrins in the Treatment of Niemann‐ Pick Disease Type C Using Crosslinked 2‐Hydroxypropyl‐β‐cyclodextrin,Small - X-MOL](https://xpic.x-mol.com/20201120%2F10.1002_smll.202004735.jpg)
Investigating the Mechanism of Cyclodextrins in the Treatment of Niemann‐ Pick Disease Type C Using Crosslinked 2‐Hydroxypropyl‐β‐cyclodextrin,Small - X-MOL
![Walgreen's Support Allows Our Twins with Niemann Pick Type C To Receive Cyclodextrin Treatments At Home | The Addi and Cassi Fund - Niemann Pick Type C Walgreen's Support Allows Our Twins with Niemann Pick Type C To Receive Cyclodextrin Treatments At Home | The Addi and Cassi Fund - Niemann Pick Type C](http://addiandcassi.com/wordpress/~hhempel/addiandcassi/wordpress/wp-content/uploads/2012/07/Hempel_Twins_Niemann_Pick_Type_C_Cyclodextrin_June_2012.jpg)